[1]
M. P. de Souza, “ARE WE READY TO INDICATE MYELODYSPLASTIC SYNDROME PATIENTS TO HEMATOPOIETIC STEM CELL TRANSPLANTATION BASED ON THEIR GENETIC STATUS?”, jbmtct, vol. 1, no. 3, pp. 16–19, Oct. 2020.